Search results
Results From The WOW.Com Content Network
Candida auris has attracted increased clinical attention because of its multiple drug resistance. [6] [7] [4]In vitro, more than 90% of C. auris isolates are resistant to fluconazole [8] [9] and a range of 3–73% of C. auris isolates are resistant to voriconazole, [9] [10] while other triazoles (posaconazole, itraconazole, and isavuconazole) display better activity.
The fungal infection has a high mortality rate (more than one in three patients with invasive Candida auris die, according to CDC data), but it’s tricky for doctors to say whether a person died ...
Drug-resistant Candida auris spread ‘worrisome’ say epidemiologists
Candida auris is an emerging multidrug-resistant (MDR) yeast that can cause invasive infections and is associated with high mortality. It was first described in 2009 after being isolated from external ear discharge of a patient in Japan.
Candida is a genus of yeasts. It is the most common cause of fungal infections worldwide and the largest genus of medically important yeasts. [1] [2] The genus Candida encompasses about 200 species. [2] Many species are harmless commensals or endosymbionts of hosts including humans.
Petri dish of candida auris in a laboratory. (Getty Images) A drug-resistant and potentially deadly fungus has been spreading rapidly through U.S. health care facilities, a new government study finds.
Candidiasis is a fungal infection due to any species of the genus Candida (a yeast). [4] When it affects the mouth, in some countries it is commonly called thrush. [3] Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. [3]
In total, the CDC recorded more than 5,600 Candida auris infections from 2013 to 2022, while more than 13,000 others identified through screenings didn’t have signs of infection.